Journal Article Summary

The article investigates the effectiveness and tolerability of a combination treatment using amlodipine and olmesartan medoxomil for patients with difficult-to-treat hypertension. This topic is significant because hypertension is a common condition, especially among older adults and those with certain risk factors like obesity and diabetes. Effective management of high blood pressure is crucial as it can significantly reduce the risk of serious health issues such as heart disease and stroke.

In this study, 1,940 patients were randomly assigned to receive either a placebo, amlodipine, olmesartan medoxomil, or a combination of both for eight weeks. The primary goal was to assess changes in diastolic blood pressure (DBP) from baseline. Results showed that the combination therapy led to greater reductions in both diastolic and systolic blood pressure compared to the individual medications alone, with a higher percentage of patients achieving their blood pressure targets across various subgroups, including those with diabetes and different racial backgrounds.

However, the study has limitations, including that it was not specifically designed to compare the combination therapy against each monotherapy within the subgroups, which may affect the interpretation of the results. Patients should be aware of potential side effects, such as peripheral edema, and discuss any concerns with their healthcare provider. It is important for individuals with hypertension to work closely with their healthcare team to determine the most effective treatment plan tailored to their specific needs and conditions.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Chrysant S G, Lee J, Melino M, Karki S, Heyrman R. Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension. Journal of Human Hypertension 2010. DOI: 10.1038/jhh.2010.5. PMID: 20164847. PMCID: PMC2963900.

Featured Pill Pals Product

Pill PalsĀ® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your medsā„¢. As a Pharmacy Benefits Management organization, Pill PalsĀ® gives patients the best cash prices on all meds. Pill PalsĀ® is part of The Health PalsĀ® Company (Health PalsĀ®, Med PalsĀ®, Skin PalsĀ® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]